FACULTY OF MEDICAL SCIENCES

Prof. Assoc. Dr. Mirela Miraçi

Prof. Assoc. Dr. Mirela Miraçi

ACADEMIC TITLE AND POSITION Prof. Assoc. Dr. / Professor
CURRENT ACADEMIC STATUS AND EDUCATIONAL BACKGROUND Assoc. Prof. Dr. Mirela Miraçi is a pharmacist and academic with extensive experience in pharmaceutical education, pharmaceutical chemistry and analysis, pharmaceutical legislation and management, and pharmacoeconomics. Her qualifications include a Pharmacy degree from the Faculty of Medicine, Tirana (1983); a one-year postgraduate course in Drug Quality Control (1984–1985); a postgraduate course in Organic Instrumental Analysis (1989–1990); a PhD in Pharmacoeconomics (2005), with a dissertation on the effects of selected beta-blockers in heart failure; and a one-year Master’s degree in Management from the University of Camerino, Italy (2006–2007). She has held the title of Associate Professor since 2015.
POSITION She worked as a pharmacist at Ndërfarma, Durrës (1983–1984), and as an academic staff member in the Department of Pharmacy, Faculty of Medicine/Faculty of Pharmacy, from September 1985 to September 2026. She formerly headed the Department of Professional Chemistry and Pharmacognosy and coordinated courses in Organization of Pharmaceutical Services, Pharmaceutical Chemistry, and Pharmaceutical Legislation and Management. Her teaching included Pharmaceutical Chemistry II, Pharmaceutical Analysis, and Pharmaceutical Legislation and Management. She taught Pharmaceutical Management at the University of Tetova for two years and taught in postgraduate/master’s programmes and the doctoral school. Since September 2026, she has been a lecturer at the Faculty of Medical Sciences, Barleti University. She also contributes to continuing education for pharmacists.
CONTRIBUTIONS Her research covers pharmacoeconomics, cost-effectiveness and budget-impact analysis of medicines, reimbursement policies, rational medicine use, pharmacovigilance and medicine safety, pharmaceutical legislation, hospital pharmacy, biologic and biosimilar medicines, and herbal products. Her publications, dating from 1984, include research on pharmacoeconomics, pharmacovigilance, the cost-effectiveness of beta-blockers, rational medicine use, the consumption and costs of biologic and biosimilar medicines (2024), the budget impact of adalimumab biosimilars (2024), and vaccination knowledge and behaviour in Albania (2025; DOI: 10.29228/jrp.386). She has participated in national and international conferences and congresses, including FIP congresses, the Euroasia Conference on Chemical Sciences, and BIOS 2024 in Toronto. She has supervised undergraduate and postgraduate theses and two doctoral candidates.
ACTIVE ENGAGEMENT AND DEVELOPMENTAL AREAS OF INTEREST Her areas of interest include pharmacoeconomics and health economics; pharmaceutical legislation and management; rational use of medicines and pharmaceutical policy; pharmacovigilance and medicine safety; pharmaceutical care and hospital pharmacy; biologic and biosimilar medicines, including consumption, costs and budget impact; medicinal and aromatic plants; and innovative pharmaceutical formulations. She has contributed to conference organisation through scientific committees and is a member of the Order of Pharmacists of Albania.